APVO
Aptevo Therapeutics
$1.36
+$0.06 (+4.62%)Oct 29, 2026
Key metrics
The numbers that frame APVO today
- Market cap
- $2.45M
- ROIC
- -612.5%
- Div yield
- 0%
- Debt / equity
- 0.7
- 52wk Low
- $1.25
- 52wk High
- $28.44
Growth
Revenue and earnings trend for APVO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about APVO
Is Aptevo Therapeutics a good buy?
No. Aptevo Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of APVO?
Aptevo Therapeutics's market capitalization is $2.45M.
What is the 52-week high for APVO stock?
The 52-week high for Aptevo Therapeutics is $28.44. The current close of $1.36 is 95.2% below that high.
What is the 52-week low for APVO stock?
The 52-week low for Aptevo Therapeutics is $1.25. The current close of $1.36 is 8.6% above that low.
Does APVO stock pay dividends?
Aptevo Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for APVO?
Aptevo Therapeutics's Debt / Equity ratio is 0.7.